These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 38356381

  • 1. The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis.
    Xiao H, Wang T, Gao B, Liu J, Li S, Ma J.
    Neurourol Urodyn; 2024 Mar; 43(3):754-766. PubMed ID: 38356381
    [Abstract] [Full Text] [Related]

  • 2. Hispidulin targets PTGS2 to improve cyclophosphamide-induced cystitis by suppressing NLRP3 inflammasome.
    Liu S, Li S, Dong Y, Qiao K, Zhao Y, Yu J.
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5819-5830. PubMed ID: 38321213
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Effects of Neurokinin-1 Receptor Antagonist in an Experimental Autoimmune Cystitis Model Resembling Bladder Pain Syndrome/Interstitial Cystitis.
    Liu BK, Jin XW, Lu HZ, Zhang X, Zhao ZH, Shao Y.
    Inflammation; 2019 Feb; 42(1):246-254. PubMed ID: 30196377
    [Abstract] [Full Text] [Related]

  • 8. Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.
    Cui X, Jing X, Lutgendorf SK, Bradley CS, Schrepf A, Erickson BA, Magnotta VA, Ness TJ, Kreder KJ, O'Donnell MA, Luo Y.
    Am J Physiol Renal Physiol; 2019 Jul 01; 317(1):F90-F98. PubMed ID: 31091120
    [Abstract] [Full Text] [Related]

  • 9. The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis.
    Kiran S, Rakib A, Singh UP.
    Front Immunol; 2022 Jul 01; 13():903834. PubMed ID: 35720309
    [Abstract] [Full Text] [Related]

  • 10. Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis.
    Tooke K, Girard B, Vizzard MA.
    Am J Physiol Renal Physiol; 2019 Jul 01; 317(7):F43-F51. PubMed ID: 30995112
    [Abstract] [Full Text] [Related]

  • 11. Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis.
    Dornelles FN, Andrade EL, Campos MM, Calixto JB.
    Br J Pharmacol; 2014 Jan 01; 171(2):452-67. PubMed ID: 24117268
    [Abstract] [Full Text] [Related]

  • 12. Si-Ni-San Ameliorates the Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome in Rats by Decreasing the Expression of Inflammatory Factors.
    Yang Y, Shi Z, Yu H, Liu M, Hu T, Han C.
    Arch Esp Urol; 2023 Jul 01; 76(5):347-356. PubMed ID: 37545154
    [Abstract] [Full Text] [Related]

  • 13. Normalization of magnesium deficiency attenuated mechanical allodynia, depressive-like behaviors, and memory deficits associated with cyclophosphamide-induced cystitis by inhibiting TNF-α/NF-κB signaling in female rats.
    Chen JL, Zhou X, Liu BL, Wei XH, Ding HL, Lin ZJ, Zhan HL, Yang F, Li WB, Xie JC, Su MZ, Liu XG, Zhou XF.
    J Neuroinflammation; 2020 Apr 02; 17(1):99. PubMed ID: 32241292
    [Abstract] [Full Text] [Related]

  • 14. A novel method for assessing bladder-related pain reveals the involvement of nerve growth factor in pain associated with cyclophosphamide-induced chronic cystitis in mice.
    Fujita M, Kasai E, Omachi S, Sakaguchi G, Shinohara S.
    Eur J Pain; 2016 Jan 02; 20(1):79-91. PubMed ID: 25820250
    [Abstract] [Full Text] [Related]

  • 15. Activation of translocator protein alleviates mechanical allodynia and bladder dysfunction in cyclophosphamide-induced cystitis through repression of BDNF-mediated neuroinflammation.
    Huang Y, Su M, Zhang C, Zhan H, Yang F, Gao Z, Zhou X, Liu B.
    Eur J Pain; 2022 Jul 02; 26(6):1234-1244. PubMed ID: 35293071
    [Abstract] [Full Text] [Related]

  • 16. Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder.
    Augé C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM.
    Eur J Pharmacol; 2013 May 05; 707(1-3):32-40. PubMed ID: 23541724
    [Abstract] [Full Text] [Related]

  • 17. A MAPP Network study: overexpression of tumor necrosis factor-α in mouse urothelium mimics interstitial cystitis.
    Yang W, Searl TJ, Yaggie R, Schaeffer AJ, Klumpp DJ.
    Am J Physiol Renal Physiol; 2018 Jul 01; 315(1):F36-F44. PubMed ID: 29465304
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of transient receptor potential cation channel subfamily M member-3 in bladder afferents is involved in chronic pain in cyclophosphamide-induced cystitis.
    Zhao M, Liu L, Chen Z, Ding N, Wen J, Liu J, Ge N, Zhang X.
    Pain; 2022 Nov 01; 163(11):2200-2212. PubMed ID: 35413036
    [Abstract] [Full Text] [Related]

  • 19. Emodin inhibits bladder inflammation and fibrosis in mice with interstitial cystitis by regulating JMJD3.
    Lai J, Liu X, Su H, Zhu Y, Xin K, Huang M, Luo S, Tang H.
    Acta Cir Bras; 2023 Nov 01; 38():e385123. PubMed ID: 38055393
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S, Casu MA, Mastinu A, Lazzari P.
    Eur J Pharmacol; 2014 Apr 15; 729():67-74. PubMed ID: 24561047
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.